Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells

References

• Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension 1992, 20, 713–736.
   PubMed Web of Science ®Google Scholar
• Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983, 49, 327–333.
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362, 801–809.
   PubMed Web of Science ®Google Scholar
• Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991, 68, 450–456.
   PubMed Web of Science ®Google Scholar
• Rivard A, Andrés V. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol 2000, 15, 557–571.
   PubMed Web of Science ®Google Scholar
• Behrendt D, Ganz P. Endothelial function. From vascular biology to clinical applications. Am J Cardiol 2002, 90, 40L–48L.
   PubMed Web of Science ®Google Scholar
• Fan YY, Ramos KS, Chapkin RS. Cell cycle related inhibition of mouse vascular smooth muscle cell proliferation by prostaglandin E1: relationship between prostaglandin E1 and intracellular cAMP levels. Prostaglandins Leukot Essent Fatty Acids 1996, 54, 101–107.
   PubMedGoogle Scholar
• Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 2001, 98, 4202–4208.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kawahara Y, Okuda M, Yokoyama M. Increasing cAMP antagonizes hypertrophic response to angiotensin II without affecting Ras and MAP kinase activation in vascular smooth muscle cells. FEBS Lett 1996, 397, 89–92.
   PubMedGoogle Scholar
• Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995, 270, 14843–14846.
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997, 9, 180–186.
   PubMed Web of Science ®Google Scholar
• Lille S, Daum G, Clowes MM, Clowes AW. The regulation of p42/p44 mitogen-activated protein kinases in the injured rat carotid artery. J Surg Res 1997, 70, 178–186.
   PubMedGoogle Scholar
• Solís-Herruzo JA, Hernández I, De la Torre P, García I, Sánchez JA, Fernández I, Castellano G, Muñoz-Yagüe T. G proteins are involved in the suppression of collagen alpha 1 (I) gene expression in cultured rat hepatic stellate cells. Cell Signal 1998, 10, 173–183.
   PubMedGoogle Scholar
• Nolly H, Carretero OA, Scicli AG. Kallikrein release by vascular tissue. Am J Physiol 1993, 265, H1209–H1214.
   PubMed Web of Science ®Google Scholar
• Saed GM, Carretero OA, MacDonald RJ, Scicli AG. Kallikrein messenger RNA in rat arteries and veins. Circ Res 1990, 67, 510–516.
   PubMedGoogle Scholar
• Oza NB, Schwartz JH, Goud HD, Levinsky NG. Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity. J Clin Invest 1990, 85, 597–600.
   PubMed Web of Science ®Google Scholar
• Toda N, Bian K, Akiba T, Okamura T. Heterogeneity in mechanisms of bradykinin action in canine isolated blood vessels. Eur J Pharmacol 1987, 135, 321–329.
   PubMedGoogle Scholar
• Briner VA, Tsai P, Schrier RW. Bradykinin: potential for vascular constriction in the presence of endothelial injury. Am J Physiol 1993, 264, F322–F327.
   Google Scholar
• Bornfeldt KE, Arnqvist HJ, Norstedt G. Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cells. J Endocrinol 1990, 125, 381–386.
   PubMed Web of Science ®Google Scholar
• Arnqvist HJ, Bornfeldt KE, Chen Y, Lindström T. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metab Clin Exp 1995, 44, 58–66.
   PubMed Web of Science ®Google Scholar
• Delafontaine P, Anwar A, Lou H, Ku L. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest 1996, 97, 139–145.
   PubMed Web of Science ®Google Scholar
• Delafontaine P.Growth factors and vascular smooth muscle cell growth responses. Europ Heart J 1998, 19 (Suppl G), G19–G22.
   PubMedGoogle Scholar
• Fath KA, Alexander RW, Delafontaine P. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circ Res 1993, 72, 271–277.
   PubMedGoogle Scholar
• Wang J, Niu W, Nikiforov Y, Naito S, Chernausek S, Witte D, LeRoith D, Strauch A, Fagin JA. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest 1997, 100, 1425–1439.
   PubMed Web of Science ®Google Scholar
• Majack RA, Clowes AW. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 1984, 118, 253–256.
   PubMedGoogle Scholar
• Brooker G, Harper JF, Terasaki WL, Moylan RD. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 1979, 10, 1–33.
   PubMedGoogle Scholar
• Nishimiya T, Daniell HB, Webb JG, Oatis J, Walle T, Gaffney TE, Halushka PV. Chronic treatment with propranolol enhances the synthesis of prostaglandins E2 and I2 by the aorta of spontaneously hypertensive rats. J Pharmacol Exp Ther 1990, 253, 207–213.
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Dixon BS, Sharma RV, Dickerson T, Fortune J. Bradykinin and angiotensin II: activation of protein kinase C in arterial smooth muscle. Am J Physiol 1994, 266, C1406–C1420.
   Google Scholar
• Velarde V, Ullian ME, Morinelli TA, Mayfield RK, Jaffa AA. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol 1999, 277, C253–C261.
   PubMedGoogle Scholar
• Borschhaubold AG. Regulation of cytosolic phospholipase A (2) by phosphorylation. Biochem Soc Trans 1998, 26, 350–354.
   PubMedGoogle Scholar
• Silfani TN, Freeman EJ. Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells. Arch Biochem Biophys 2002, 402, 84–93.
   PubMedGoogle Scholar
• Chen Y, Capron L, Magnusson JO, Wallby LA, Arnqvist HJ. Insulin-like growth factor-1 stimulates vascular smooth muscle cell proliferation in rat aorta in vivo. Growth Horm IGF Res 1998, 8, 299–303.
   PubMedGoogle Scholar
• Yang CM, Chien CS, Ma YH, Hsiao LD, Lin CH, Wu C. Bradykinin B2 receptor-mediated proliferation via activation of the Ras/Raf/MEK/MAPK pathway in rat vascular smooth muscle cells. J Biomed Sci 2003, 10, 208–218.
   PubMed Web of Science ®Google Scholar
• el-Dahr SS, Dipp S, Yosipiv IV, Baricos WH. Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cells. Kidney Int 1996, 50, 1850–1855.
   PubMedGoogle Scholar
• McEachern AE, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, Fujisaki J, Aldrich RW, Jarnagin K. Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci USA 1991, 88, 7724–7728.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yee D. Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. Breast Cancer Res 2000, 2, 170–175.
   PubMed Web of Science ®Google Scholar
• Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993, 363, 45–51.
   PubMed Web of Science ®Google Scholar
• Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995, 9, 726–735.
   PubMed Web of Science ®Google Scholar
• El-Haroun H, Bradbury D, Clayton A, Knox AJ. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4. Circ Res 2004, 94, 353–361.
   PubMedGoogle Scholar